CACA guidelines for holistic integrative management of esophageal carcinoma
-
Published:2023-09-25
Issue:1
Volume:2
Page:
-
ISSN:2731-4529
-
Container-title:Holistic Integrative Oncology
-
language:en
-
Short-container-title:Holist Integ Oncol
Author:
Gong Lei, Bai Ming, Dai Liang, Guo Xufeng, Leng Xuefeng, Li Zhigang, Lu Zhihao, Mao Teng, Pang Qingsong, Shen Lin, Sun Yifeng, Yang Hong, Yin Jun, Zhang Hongdian, Zhang Wencheng, Zhao Gang, Zheng Bin, Yang Yueyang, Ba Yi, Chen Chun, Chen Haiquan, Chen Longqi, Deng Ting, Fan Qingxia, Fang Wentao, Fu Xiangning, Huang Jing, Li Xiaofei, Li Yin, Liu Shuoyan, Liu Yongyu, Ma Jianqun, Mao Weimin, Ren Jingli, Tan Lijie, Tang Peng, Wang Lvhua, Wang Qun, Wei Wenqiang, Xue Qi, Zhang Renquan, Chen Keneng, Fu Jianhua, Liu Junfeng, Han Yongtao, He Jie, Yu Zhentao, Mao YoushengORCID
Abstract
AbstractEsophageal carcinoma (EC) is a common malignant tumor of the upper digestive tract worldwide. An analysis of the latest data from cancer centers in China showed that the incidence of EC and the number of deaths due to EC in China in 2015 were 266,000 and 188,000, respectively, ranking sixth (6.3%) and fourth (8.0%) among all malignant tumors. The early diagnosis and treatment of EC and standardized diagnosis and treatment are important tasks for EC healthcare professionals in various centers across the country. At present, the 8th edition of the EC staging system jointly released by Union for International Cancer Control (UICC) and American Joint Committee on Cancer (AJCC) is the most recent, authoritative and widely used EC staging standard. The EC professional committee of the Chinese Anti-Cancer Association also organizes the "EC Standardization Campaign in China" every year to promote the development of EC diagnostic and treatment norms throughout the country. Since 2011, the EC Committee of the Chinese Anti-Cancer Association has published the Guidelines for Standardized Diagnosis and Treatment of EC. Considering the increasing number of EC clinical studies and the continuous progress in diagnostic and treatment technologies in recent years, the updated Guidelines will include the latest progress in the diagnosis and treatment of EC, with a goal of promoting the forward development of EC diagnosis and treatment in clinical practice.
Publisher
Springer Science and Business Media LLC
Reference141 articles.
1. Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries[J]. CA Cancer J Clin. 2021;71(3):209–49. 2. Sung KX, Zheng RS, Zhang SW, et al. Analysis of the incidence and mortality of malignant tumors in China in 2015[J]. China Oncology. 2019;28(01):1–11. 3. Zhou JC, Zheng RS, Zhang SW, et al. Trends in the incidence and age of esophageal cancer in cancer registration areas in China from 2000 to 2015[J]. Chin J Cancer Prev Treat. 2020;27(18):1437–42. 4. Chen F, Wang YQ. Analysis of the disease burden and changing trend of esophageal cancer in China from 1990 to 2019[J]. China Oncology. 2021;30(06):401–7. 5. Zhang LY, Chen Q, Liu SZ, et al. Estimation of esophageal cancer incidence and death in Henan Province in 2015[J]. Cancer Prevention and Treatment. 2019;32(11):978–83.
|
|